LifeSensors is Attending ASCB | EMBO Cell Bio 2022

LifeSensors is Attending ASCB | EMBO Cell Bio 2022 MALVERN, PA., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration diagnostics will present new technologies that target ubiquitin E3 ligases and uncover unique molecules. The company will be presenting two posters. One presentation focuses on […]
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference

LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference MALVERN, Pa., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glue drug discovery and neurodegeneration diagnostics has been invited to speak at Discovery on Target 2022. Dr. Karteek Kadimisetty, LifeSensors’ Director of Research […]
LifeSensors Attending the 5th Annual Targeted Protein Degradation Summit

LifeSensors Attending the 5th Annual Targeted Protein Degradation Summit MALVERN, PA., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, Molecular Glues, and neurodegeneration diagnostics has been invited to speak at 5th Targeted Protein Degradation Summit in Boston MA. Dr. Karteek Kadimisetty, LifeSensors’ Director of Research and Development will be presenting […]